| __timestamp | Dr. Reddy's Laboratories Limited | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 38783000000 | 6795238 |
| Thursday, January 1, 2015 | 42585000000 | 7454247 |
| Friday, January 1, 2016 | 45702000000 | 10345862 |
| Sunday, January 1, 2017 | 46372000000 | 16984203 |
| Monday, January 1, 2018 | 46910000000 | 16187290 |
| Tuesday, January 1, 2019 | 48890000000 | 9299233.54 |
| Wednesday, January 1, 2020 | 50129000000 | 19232000 |
| Friday, January 1, 2021 | 54559000000 | 23611000 |
| Saturday, January 1, 2022 | 62081000000 | 26700000 |
| Sunday, January 1, 2023 | 105931000000 | 28215000 |
| Monday, January 1, 2024 | 77201000000 |
Unlocking the unknown
In the ever-evolving pharmaceutical landscape, understanding spending patterns is crucial. Dr. Reddy's Laboratories Limited and Summit Therapeutics Inc. offer a fascinating contrast in their Selling, General, and Administrative (SG&A) expenses over the past decade.
From 2014 to 2023, Dr. Reddy's Laboratories consistently increased its SG&A expenses, peaking in 2023 with a staggering 173% increase from 2014. This reflects their aggressive market expansion and strategic investments. In contrast, Summit Therapeutics Inc. exhibited a more modest growth, with their SG&A expenses increasing by approximately 315% over the same period, albeit from a much smaller base.
The data highlights Dr. Reddy's robust financial strategy, while Summit's growth, though significant, suggests a more cautious approach. Missing data for 2024 suggests potential shifts in strategy or reporting. These insights are invaluable for investors and industry analysts alike.
Operational Costs Compared: SG&A Analysis of Amgen Inc. and Summit Therapeutics Inc.
Selling, General, and Administrative Costs: Sanofi vs Dr. Reddy's Laboratories Limited
Who Optimizes SG&A Costs Better? Regeneron Pharmaceuticals, Inc. or Summit Therapeutics Inc.
Cost Management Insights: SG&A Expenses for Teva Pharmaceutical Industries Limited and Dr. Reddy's Laboratories Limited
Comparing SG&A Expenses: Viatris Inc. vs Summit Therapeutics Inc. Trends and Insights
Summit Therapeutics Inc. vs Blueprint Medicines Corporation: SG&A Expense Trends
Breaking Down SG&A Expenses: Summit Therapeutics Inc. vs Rhythm Pharmaceuticals, Inc.
Summit Therapeutics Inc. vs Agios Pharmaceuticals, Inc.: SG&A Expense Trends
Dr. Reddy's Laboratories Limited vs Walgreens Boots Alliance, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Dr. Reddy's Laboratories Limited and TG Therapeutics, Inc.
Dr. Reddy's Laboratories Limited and Celldex Therapeutics, Inc.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Dr. Reddy's Laboratories Limited or Evotec SE